Dewpoint Therapeutics, Inc.
Biotechnology
Dewpoint Therapeutics focuses on drug discovery across oncology, neurodegenerative, cardiopulmonary, and metabolic diseases using an AI-powered platform. It specializes in visualizing and targeting biomolecular condensates to prevent harmful protein aggregation, collaborating with top academic and pharmaceutical entities to develop innovative therapies.
Founded: 2018
Ameet Nathwani Chief Executive Officer & Board Member |
Lori Escobedo Chief People Officer |
Isaac Klein Chief Scientific Officer |
Dean Mula Vice President & Corporate Controller |
Anthony Hyman Co-Founder & Board Member |
Richard Young Co-Founder & Board Member |